The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Atlas Venture Opportunity Fund I, L.p. since 2019.
This trader's CIK number is 1759241.
At the time of last reporting, Atlas Venture Opportunity Fund I, L.p. was the Officer of Xilio Therapeutics, Inc.. (stock ticker symbol XLO).
Also see all insider trading activities at Xilio Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | AKRO | 270,000 | $4,320,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | XLO | 187,500 | $3,000,000 | 0 | $0 | 0 | $0 |
1. Akero Therapeutics, Inc. (AKRO)
2. Xilio Therapeutics, Inc. (XLO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-24 | AKRO | Buy | 270,000 | 16.00 | 4,320,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-10-26 | XLO | Buy | 187,500 | 16.00 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atlas Venture Opportunity Fund I, L.p. (Officer of Xilio Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.